TRAW · Traws Pharma, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“Based on current projections, the Company believes that it does not have sufficient cash and cash equivalents to support its operations for more than one year following the date that these financial statements are issued. As a result of these conditions, substantial doubt exists about the Company’s ability to continue as a going concern.”